Importantly, other studies have provided direct evidence showing that blocking axonal transport of LAMP1-positive endolysosomal organelles sufficiently triggers an increase in Aβ42 production in human iPSC-derived neurons without overexpression of mutant APP or PS1 and augments plaque pathology in a mouse model of AD [70,71]. Here, APP is linked to Alzheimer disease.